Key Takeaways
Carlyle Group (NASDAQ: CG) finds itself at a pivotal juncture, with CEO Harvey Schwartz championing a "fundraising super cycle" to propel the alternative asset manager to new heights by 2028. This ambitious vision, unveiled in February 2026, aims to systematically reshape the firm, which has historically lagged behind mega-cap peers like Blackstone and Apollo. However, the narrative faces immediate scrutiny following Carlyle's Q1 2026 earnings report on May 7, 2026, where the company posted an actual EPS of $0.89, missing analyst estimates of $0.92 by 3.26%. This marks a notable decline from the $1.14 EPS reported in Q1 2025, raising questions about the immediate path to its aggressive long-term targets.
Despite the recent earnings miss, management, including CFO Justin Plouffe, has reaffirmed confidence in achieving or exceeding its 2028 targets. These include boosting fee-related earnings (FRE) to over $1.9 billion from $1.2 billion in 2025, and increasing distributable earnings per common share (DE/share) to more than $6 from $4.02 in 2025. The firm's strategic plan, detailed in its February 2026 shareholder update, is described as a "rigorous, bottom-up build across our business," indicating a calculated approach rather than mere optimism. The market's initial reaction to the 2028 targets in February 2026 saw shares rise over 6% before settling to trade 3.6% higher on the day, reflecting a cautious but positive reception to the long-term outlook.
Schwartz, who joined Carlyle three years ago, has been vocal about "systematically reshaping" the company, focusing on leadership, capital management, and operating structure. This overhaul has already yielded results, with FRE growing from a low of $800 million to $1.2 billion and margins improving from 37% to 47% by 2025. The current market price of CG stock stands at $45.66 as of May 27, 2026, near the lower end of its 52-week range of $43.98 to $69.85. This suggests that while the market acknowledges the strategic shift, it remains somewhat skeptical of the firm's ability to consistently execute, especially given the Q1 2026 earnings performance. The upcoming Q2 2026 earnings call on August 5, 2026, with an estimated EPS of $0.93, will be crucial in demonstrating whether the firm can regain its earnings momentum.
Carlyle's ambitious target of raising at least $200 billion in new capital inflows by the end of 2028 is a cornerstone of its growth strategy, significantly outpacing the $158 billion raised between 2023 and 2025. This capital infusion is not evenly distributed across its segments but rather strategically allocated to capitalize on specific market opportunities and enhance revenue stability. The firm manages approximately $477 billion in total assets under management (AUM) as of March 31, 2026, and this new fundraising initiative aims to substantially grow that base.
The breakdown of the $200 billion target reveals a clear pivot: $90 billion is earmarked for global credit strategies, $60 billion for the AlpInvest secondaries unit, and $50 billion for private equity. This allocation underscores Carlyle's strategic shift towards more stable, fee-generating businesses like credit and secondaries, which offer more predictable revenue streams compared to the often lumpy performance fees from traditional private equity. The Q1 2026 report highlighted inflows of $6.8 billion, driven notably by cross-strategy SMAs and AlpInvest wealth products, demonstrating early traction in these targeted areas.
Carlyle's Global Credit segment, with $209.5 billion in AUM as of March 31, 2026, is positioned as a primary growth engine. Management has defended the durability of its CLO structures and plans to drive growth through new opportunistic funds and expansion in the private Business Development Company (BDC) space, which typically carry higher fee profiles than legacy CLOs. The firm's disciplined credit profile, with a non-accrual rate of only 1% in direct lending and a default rate in structured credit at half the industry average, provides a strong foundation for this expansion.
The AlpInvest platform, with $102.0 billion in AUM as of December 31, 2025, is also undergoing a transformation, evolving from a traditional secondaries business into a comprehensive solutions provider. This evolution, coupled with the projected $60 billion in inflows, is expected to accelerate management fees over the next two years. Meanwhile, the Global Private Equity segment, holding $159.0 billion in AUM as of March 31, 2026, will contribute $50 billion to the fundraising goal. Notably, Carlyle recently launched a first-of-its-kind $5 billion investment solution for its next U.S. buyout fund, securing a cornerstone commitment at full fees, which management noted has generated significant interest from other LPs. This innovative approach to capital raising could be key to meeting its ambitious targets.
Carlyle's multi-year plan hinges not just on raising capital, but on translating those inflows into robust fee-related earnings (FRE) and attractive shareholder returns. The firm targets over $1.9 billion in FRE by 2028, a significant jump from $1.2 billion in 2025, representing a 15%+ three-year CAGR. This growth is expected to be driven by an acceleration in management fees, particularly from the "super cycle" of fundraising in AlpInvest and Private Equity. The Q1 2026 earnings call noted that management fees are projected to pick up in coming quarters, alongside an anticipated increase in transaction fee revenue from large deals like the $8 billion BASF coatings carve-out and the $3 billion MAI Capital acquisition.
A key component of Carlyle's commitment to shareholder returns is its active share repurchase program. In February 2026, the company approved a $2 billion buyback, signaling strong confidence in its earnings outlook and capital generation. As of the Q1 2026 earnings call, $1.9 billion remained on this authorization, indicating a substantial ongoing commitment to reducing share count and boosting EPS. This buyback, combined with a consistent dividend, aims to provide tangible returns to investors.
Speaking of dividends, Carlyle has reaffirmed its quarterly dividend of $0.35 per share, translating to an annual yield of approximately 3.1% based on the current stock price of $45.66. While this consistent payout appeals to income-focused investors, its sustainability is directly tied to the firm's ability to restore stable earnings growth. The dividend payout ratio currently stands at 92.4% based on TTM EPS of $1.52, suggesting that future earnings growth is critical to maintaining or increasing this payout without straining capital.
Executive compensation is also aligned with long-term shareholder value. Carlyle emphasizes a pay-for-performance approach, with a large share of compensation delivered in restricted stock units (RSUs) and performance stock units (PSUs). While CEO Harvey Schwartz's 2025 compensation of $7.15 million included a $1 million salary with no stock, Co-President John Redett received $43.62 million in stock, and COO Lindsay LoBue received $23.92 million in stock, aligning their incentives with the firm's equity performance. This structure, alongside stock ownership guidelines and clawback policies, aims to ensure management is invested in achieving the 2028 financial targets, including the projected $6+ in distributable earnings per share.
Despite Carlyle's optimistic outlook and strategic pivot, several significant risks could impede its path to achieving the ambitious 2028 targets. The asset management industry, particularly private markets, remains susceptible to broader economic and market volatility. The Q1 2026 earnings report noted lower net realized performance revenue year-over-year, primarily due to the composition of exits occurring in funds not yet realizing carry. While management expects to begin realizing carry from several funds in the remainder of 2026, including Japan Buyout, Europe Tech, and financial services funds, the timing and magnitude of these realizations are inherently unpredictable.
Intense competition is another formidable challenge. Major peers like Blackstone, KKR, and Apollo are aggressively expanding into similar private credit and secondaries areas. This heightened competition could limit Carlyle's ability to scale as quickly, secure premium fees, or attract the desired level of capital inflows. The firm's forecast annual revenue growth rate of 13.74% is projected to beat the US Asset Management industry's average of 5.58%, but it is not forecast to beat the broader US market's average of 13.82%, indicating that outperformance against the broader market may be challenging.
Furthermore, the wealth channel, a growing source of capital for alternative asset managers, is experiencing "some redemption pressure," as noted during the Q1 2026 earnings call. While Carlyle's CTAC fund's daily marking and diversification provide a competitive advantage, management expects this period of elevated redemptions to persist across the industry for a while. This trend could slow the pace of fundraising, particularly in products designed for individual investors, and impact the overall $200 billion inflow target.
Specific fund performance also presents risks. The context mentions challenges in Carlyle's global private equity segment, with assets like Oksut and Mount Milligan showing underperforming production metrics. Mount Milligan, which constitutes approximately 50% of net asset value and accounts for around 70% of production through the end of 2027, has consistently missed initial production guidance and is projected to underperform industry peers by roughly 25%. While an organic growth pipeline is anticipated, it is not expected to materialize until 2028-2029, adding uncertainty to future performance. The firm's 2025 net income growth of -20.7% and EPS growth of -21.3% underscore the importance of successful exits and new fund performance to reverse these trends.
Carlyle Group's current stock price of $45.66 (as of May 27, 2026) positions it at a critical juncture for investors evaluating its growth potential against inherent risks. The stock is trading significantly below its 52-week high of $69.85, suggesting that the market has priced in some of the challenges and uncertainties surrounding its turnaround. However, Wall Street analysts maintain a generally positive outlook, with a consensus "Buy" rating from 25 analysts (14 Buy, 10 Hold, 1 Sell). The average analyst price target is $62.86, with a median of $65.00, implying a potential upside of approximately 37.7% from the current price. The highest target stands at $74.00, while the lowest is $45.00, indicating a range of expert opinions.
From a valuation perspective, Carlyle's TTM P/E ratio is 30.01, which is higher than some peers but needs to be considered in the context of its projected earnings growth. Analysts forecast a substantial increase in EPS, with an average of $4.11 for 2026, $5.29 for 2027, and $6.09 for 2028. This implies a forward P/E ratio that would be significantly lower, potentially making the stock more attractive. For instance, using the 2027 EPS forecast of $5.29, the forward P/E would be around 8.6x (45.66 / 5.29), which is considerably below its 5-year average of 22x (from general knowledge, not provided in context). This suggests that if Carlyle achieves its earnings targets, the stock could be undervalued at current levels.
The forecast annual earnings growth rate of 59.9% for Carlyle is projected to beat the US Asset Management industry's average of 32.18% and the broader US market's average of 33.49%. This strong earnings growth potential is a key driver of analyst optimism. Furthermore, the forecast Return on Equity (ROE) for CG is 42.17%, which is considered strong and significantly higher than its TTM ROE of 9.7%. This indicates that if the firm executes its strategy, it could generate substantial returns for shareholders.
However, investors must weigh these optimistic forecasts against the firm's current TTM financial fundamentals, which show a net income decline of -20.7% and a negative free cash flow (FCF) yield of -5.6%. While operating cash flow saw a robust 292.6% growth in FY2025, the negative FCF suggests capital deployment or other operational uses are consuming cash. The current P/FCF of -17.91 further highlights this. The market's current valuation of $45.66 likely reflects a cautious stance, waiting for tangible evidence of the "super cycle" translating into consistent, positive earnings and free cash flow before fully pricing in the ambitious 2028 targets.
Carlyle Group (CG) is in the midst of a critical transformation, with CEO Harvey Schwartz's ambitious 2028 targets setting a clear, albeit challenging, path forward. While the recent Q1 2026 EPS miss highlights execution risks, the strategic pivot towards credit and secondaries, coupled with a substantial share buyback, positions the firm for potentially significant long-term growth. Investors should closely monitor the upcoming earnings calls and fundraising progress to assess whether Carlyle can truly deliver on its "super cycle" promise and unlock the substantial upside projected by Wall Street analysts.
Want deeper research on any stock? Try Kavout Pro for AI-powered analysis, smart signals, and more. Already a member? Add credits to run more research.
